163 related articles for article (PubMed ID: 9484953)
1. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
Lobert S; Frankfurter A; Correia JJ
Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
[TBL] [Abstract][Full Text] [Related]
2. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Origin of Differential Binding Affinities of Human Tubulin Isotypes αβII, αβIII and αβIV for DAMA-Colchicine Using Homology Modelling, Molecular Docking and Molecular Dynamics Simulations.
Kumbhar BV; Borogaon A; Panda D; Kunwar A
PLoS One; 2016; 11(5):e0156048. PubMed ID: 27227832
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
Owellen RJ; Hartke CA; Dickerson RM; Hains FO
Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
[TBL] [Abstract][Full Text] [Related]
5. Biochemical effects of Navelbine on tubulin and associated proteins.
Fellous A; Ohayon R; Vacassin T; Binet S; Lataste H; Krikorian A; Couzinier JP; Meininger V
Semin Oncol; 1989 Apr; 16(2 Suppl 4):9-14. PubMed ID: 2496470
[TBL] [Abstract][Full Text] [Related]
6. Influence of guanine nucleotides on vincristine binding in tumor cytosols and purified tubulin: evidence for an inhibitor of vincristine binding.
Bowman LC; Houghton JA; Houghton PJ
J Cell Physiol; 1990 Sep; 144(3):376-82. PubMed ID: 2391373
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
Jordan MA; Himes RH; Wilson L
Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
[TBL] [Abstract][Full Text] [Related]
8. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on axonal fibrillar organelles in vitro.
Donoso JA; Green LS; Heller-Bettinger IE; Samson FE
Cancer Res; 1977 May; 37(5):1401-7. PubMed ID: 558047
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells.
Van Belle SJ; De Smet MC; De Mey JE; Storme GA
Anticancer Res; 1991; 11(1):465-71. PubMed ID: 2018383
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of interaction of vinca alkaloids with tubulin: catharanthine and vindoline.
Prakash V; Timasheff SN
Biochemistry; 1991 Jan; 30(3):873-80. PubMed ID: 1988072
[TBL] [Abstract][Full Text] [Related]
11. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
[TBL] [Abstract][Full Text] [Related]
13. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
Bai R; Pettit GR; Hamel E
Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935
[TBL] [Abstract][Full Text] [Related]
14. Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids.
Pain J; Sirotnak FM; Barrueco JR; Yang CH; Biedler JL
J Cell Physiol; 1988 Aug; 136(2):341-7. PubMed ID: 3045133
[TBL] [Abstract][Full Text] [Related]
15. The action of two Vinca alkaloids on B16 melanoma in vitro.
Donoso JA; Himes RH
Cancer Biochem Biophys; 1984 Jun; 7(2):133-45. PubMed ID: 6467174
[TBL] [Abstract][Full Text] [Related]
16. Identification of Vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine.
Safa AR; Glover CJ; Felsted RL
Cancer Res; 1987 Oct; 47(19):5149-54. PubMed ID: 3621200
[TBL] [Abstract][Full Text] [Related]
17. Aging of tubulin at neutral pH: the destabilizing effect of vinca alkaloids.
Prakash V; Timasheff SN
Arch Biochem Biophys; 1992 May; 295(1):137-45. PubMed ID: 1575510
[TBL] [Abstract][Full Text] [Related]
18. Advances in vinca-alkaloids: Navelbine.
Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
[TBL] [Abstract][Full Text] [Related]
19. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
Bai RL; Pettit GR; Hamel E
J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells.
King KL; Boder GB
Cancer Chemother Pharmacol; 1979; 2(4):239-42. PubMed ID: 455582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
